[HTML][HTML] Arrhythmias after COVID-19 vaccination: have we left all stones unturned?
N Cocco, G Leibundgut, F Pelliccia… - International Journal of …, 2023 - mdpi.com
SARS-CoV-2 vaccination offered the opportunity to emerge from the pandemic and, thereby,
worldwide health, social, and economic disasters. However, in addition to efficacy, safety is …
worldwide health, social, and economic disasters. However, in addition to efficacy, safety is …
[HTML][HTML] Beauty and the beast: host microRNA-155 versus SARS-CoV-2
KI Papadopoulos, A Papadopoulou, TC Aw - Human Cell, 2023 - Springer
Severe acute respiratory coronavirus 2 (SARS-CoV-2) infection in the young and healthy
usually results in an asymptomatic or mild viral syndrome, possibly through an erythropoietin …
usually results in an asymptomatic or mild viral syndrome, possibly through an erythropoietin …
[HTML][HTML] Age and genotype dependent erythropoietin protection in COVID-19
KI Papadopoulos, W Sutheesophon… - World Journal of Stem …, 2021 - ncbi.nlm.nih.gov
Erythropoietin (EPO) is the main mediator of erythropoiesis and an important tissue
protective hormone that appears to mediate an ancestral neuroprotective innate immune …
protective hormone that appears to mediate an ancestral neuroprotective innate immune …
Gitelman's and Bartter's syndromes: From genetics to the molecular basis of hypertension and more
V Ravarotto, G Bertoldi, LF Stefanelli… - Kidney and Blood …, 2022 - karger.com
Abstract Background: Gitelman's and Bartter's syndromes (GS/BS) are rare genetic
tubulopathies characterized by electrolyte imbalance and activation of the renin-angiotensin …
tubulopathies characterized by electrolyte imbalance and activation of the renin-angiotensin …
[HTML][HTML] Impaired ACE2 glycosylation and protease activity lowers COVID‐19 susceptibility in Gitelman's and Bartter's syndromes
The SARS-CoV-2 pandemic (COVID-19) has focused attention on the renin angiotensin
system (RAS), specifically angiotensin-converting enzyme 2 (ACE2) as it serves as the entry …
system (RAS), specifically angiotensin-converting enzyme 2 (ACE2) as it serves as the entry …
[HTML][HTML] Angiotensin II, RAS Activation, and RAS Blockers in COVID-19: Unambiguous Evidence
The renin-angiotensin system (RAS) during COVID-19 pandemic has captured the interest
as the severe coronavirus 2 (SARS-CoV-2) causing COVID-19 uses angiotensin-converting …
as the severe coronavirus 2 (SARS-CoV-2) causing COVID-19 uses angiotensin-converting …
[HTML][HTML] COVID 19, Paxlovid and the lesson from rare genetic diseases with naturally occurring protection from SARS-CoV-2 infection
LA Calò, L Sgarabotto, LF Stefanelli, V Di Vico… - Journal of …, 2023 - Springer
The coronavirus disease 2019 (COVID-19) pandemic, resulting from infection with SARS-
CoV-2 has focused intense scientific interest on Angiotensin Converting Enzyme (ACE) 2, as …
CoV-2 has focused intense scientific interest on Angiotensin Converting Enzyme (ACE) 2, as …
The counter-regulatory arm of the renin-angiotensin system and COVID-19: insights from Gitelman's and Bartter's syndromes
LF Stefanelli, L Gobbi, V Ravarotto… - Journal of …, 2022 - journals.lww.com
The COVID-19 pandemic has focused the interest on the renin-angiotensin system (RAS),
as it has a role not only in the infection process but also in the lung injury, which represents …
as it has a role not only in the infection process but also in the lung injury, which represents …
[HTML][HTML] “Every Cloud Has a Silver Lining”: How Three Rare Diseases Defend Themselves from COVID-19 and What We Have Learnt from It
M Cacciapuoti, I Caputo, LF Stefanelli, PA Davis… - Clinics and …, 2024 - mdpi.com
The process of SARS-CoV-2 infection, responsible for the COVID-19 pandemic, is carried
out through different steps, with the interaction between ACE2 and Spike protein (S) being …
out through different steps, with the interaction between ACE2 and Spike protein (S) being …